APA (7th ed.) Citation

T, A. H., K, A., S, A. H., T, A., R, A. H., S, Y., . . . K, A. (2024). Beyond clinical trials: Real-world impact of immunotherapy on NSCLC in Jordan. Frontiers in oncology, 14, 1369126. https://doi.org/10.3389/fonc.2024.1369126

Chicago Style (17th ed.) Citation

T, Abu Hejleh, et al. "Beyond Clinical Trials: Real-world Impact of Immunotherapy on NSCLC in Jordan." Frontiers in Oncology 14 (2024): 1369126. https://doi.org/10.3389/fonc.2024.1369126.

MLA (9th ed.) Citation

T, Abu Hejleh, et al. "Beyond Clinical Trials: Real-world Impact of Immunotherapy on NSCLC in Jordan." Frontiers in Oncology, vol. 14, 2024, p. 1369126, https://doi.org/10.3389/fonc.2024.1369126.